Submission Details

Submitter:

Classification:
Definitive
GENCC:100001
Gene:
Disease:
Floating-Harbor syndrome
Mode Of Inheritance:
Autosomal dominant
Evaluated Date:
08/01/2023
Evidence/Notes:

SRCAP was first reported in relation to autosomal dominant Floating Harbor Syndrome (FHS) in 2012 (Hood et al., PMID: 22265015). A rare genetic disorder, FHS is characterized by short stature, delayed bone age, delayed speech development, and distinctive facial features – the face is triangular with deep-set eyes, long eyelashes, bulbous nose, wide columella, short philtrum, and thin lips. Additional phenotypes including mild to moderate intellectual disability have also been reported. The specific phenotypes and severity of FHS vary greatly from one person to another and also by age. Fourteen variants (frameshift (9) and nonsense (5)) mostly de novo (9), reported in 14 probands in 5 publications are included in this curation (PMIDs: 22265015, 22965468, 25433523, 23621943, 30425916). Two of the variants, c.7330C>T (p.Arg2444*) and c.7303C>T (p.Arg2435*) on exon 34, are recurrent and have been reported in sixteen and ten unrelated individuals, respectively (PMID: 22265015, 22965468, 25433523, 30425916, 23621943). The mechanism of pathogenicity is reported as haploinsufficiency. While more evidence is available in the literature, the maximum score for genetic evidence (12 points) has been reached. In summary, there is definitive evidence to support the relationship between SRCAP and Floating Harbor Syndrome. This has been repeatedly demonstrated in both the research and clinical diagnostic settings and has been upheld over time. This classification was approved by the ClinGen Intellectual Disability and Autism expert panel on August 1, 2023 (SOP Version 9).

PubMed IDs:
22265015 22965468 25433523 30425916
Public Report:
Assertion Criteria:
Submitter Submitted Date:
12/05/2025

The GenCC data are available free of restriction under a CC0 1.0 Universal (CC0 1.0) Public Domain Dedication. The GenCC requests that you give attribution to GenCC and the contributing sources whenever possible and appropriate. The accepted Flagship manuscript is now available from Genetics in Medicine (https://www.gimjournal.org/article/S1098-3600(22)00746-8/fulltext).

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. The GenCC does not independently verify the submitted information. Though the information is obtained from sources believed to be reliable, no warranty, expressed or implied, is made regarding accuracy, adequacy, completeness, reliability or usefulness of any information. This disclaimer applies to both isolated and aggregate uses of the information. The information is provided on an "as is" basis, collected through periodic submission and therefore may not represent the most up-to-date information from the submitters. If you have questions about the medical relevance of information contained on this website, please see a healthcare professional; if you have questions about specific gene-disease claims, please contact the relevant sources; and if you have questions about the representation of the data on this website, please contact gencc@thegencc.org.